lifestyle.celebhomes.net
Home
Sample Page
Author:
Alzheimer’s Drug Discovery Foundation
Goodes Prize Recipient Dr. Jeff Cummings’ 2026 Alzheimer’s Drug Pipeline Report Signals New Era of Biology-Driven Approaches
May 5, 2026
ADDF Launches New Phase of $150 Million Diagnostics Accelerator Initiative to Power Next Generation of Alzheimer’s Precision Medicine Worldwide
March 17, 2026
Alzheimer’s Drug Discovery Foundation Appoints Isobel Coleman as Chief Executive Officer to Lead Next Era of Alzheimer’s Breakthroughs
March 11, 2026
ADDF Bolsters Leadership Amid Transformative Moment in Alzheimer’s Research, Naming Gavin Cook and David Dolby to its Board and Appointing Jane McIntosh as Interim CEO
December 17, 2025
New Data from Semaglutide Trials Provides Critical Insights to Guide Next Generation of Therapies Targeting Alzheimer’s Pathobiology
December 5, 2025
Readout of Phase 3 Semaglutide Trials Marks Critical Moment in Alzheimer’s Research and Suggests Potential for Combination Therapies
November 25, 2025
Alzheimer’s Drug Discovery Foundation Launches Milestones in Motion Campaign and Announces Fifth Season of Symposium Series in Palm Beach
November 22, 2025